CCR3 antagonists: a survey of the patent literature

D6 and the atypical chemokine receptor family: Novel regulators of immune and inflammatory processes

(2009) Gerard J. Graham   EUROPEAN JOURNAL OF IMMUNOLOGY

Chemokine receptor antagonists: Part 1

(2009) James E Pease et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

(2009) Pranabashis Haldar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

(2009) Parameswaran Nair et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antisense Therapy against CCR3 and the Common Beta Chain Attenuates Allergen-induced Eosinophilic Responses

(2008) Gail M. Gauvreau et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Urea based CCR3 antagonists employing a tetrahydro-1,3-oxazin-2-one spacer

(2008) T.G. Murali Dhar et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Interfering with chemokines and chemokine receptors as potential new therapeutic strategies

(2008) Mario Milco D'Elios et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: The discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis

(2007) Joseph B. Santella et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists

(2007) Daniel S. Gardner et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS